Australia (AU)

Nested sampling for physical scientists (2022) Ashton G, Bernstein N, Buchner J, Chen X, Csányi G, Fowlie A, Feroz F, et al. Journal article, Review article First studies of the diffuse X-ray emission in the Large Magellanic Cloud with eROSITA (2022) Sasaki M, Knies J, Haberl F, Maitra C, Kerp J, Bykov AM, Dennerl K, et al. Journal article Identification of SRGt 062340.2-265751 as a bright, strongly variable, novalike cataclysmic variable (2022) Schwope A, Buckley DAH, Kawka A, König O, Lutovinov A, Maitra C, Mereminskiy I, et al. Journal article Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2022) Dorling L, Carvalho S, Allen J, Parsons MT, Fortuno C, Gonzalez-Neira A, Heijl SM, et al. Journal article Presence of Magnetic Resonance Imaging-Defined Inflammation Particularly in Overweight and Obese Women Increases Risk of Radiographic Knee Osteoarthritis: The POMA Study (2022) Roemer FW, Guermazi A, Hannon MJ, Fujii T, Omoumi P, Hunter DJ, Eckstein F, Kwoh CK Journal article Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022 (2022) Pimentel-Nunes P, Libanio D, Bastiaansen BAJ, Bhandari P, Bisschops R, Bourke MJ, Esposito G, et al. Journal article Multivariable Modeling of Biomarker Data From the Phase I Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium (2022) Hunter DJ, Deveza LA, Collins JE, Losina E, Katz JN, Nevitt MC, Lynch JA, et al. Journal article Erratum: Correction to: Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis (Human reproduction update (2022) 28 3 (400-416)) (2022) Khattak H, Malhas R, Craciunas L, Afifi Y, Amorim CA, Fishel S, Silber S, et al. Journal article, Erratum 10-YEAR CLINICAL EVENTS AVOIDED IN DIABETIC AND CHRONIC KIDNEY DISEASE HYPERTENSION PATIENTS TREATED WITH RADIOFREQUENCY RENAL DENERVATION: PROJECTIONS BASED ON 3-YEAR DATA FROM THE GLOBAL SYMPLICITY REGISTRY (2022) Schmieder R, Cao K, Esler M, Kandzari D, Lobo M, Sharp A, Mancia G, et al. Conference contribution KEYNOTE-522: Neoadjuvant Pembrolizumab plus Chemotherapy vs Placebo plus Chemotherapy Followed by Adjuvant Pembrolizumab vs Placebo for Early-stage Triple Negative Breast Cancer (2022) Mcarthur H, Cortes J, Dent R, Pusztai L, Kuemmel S, Bergh J, Denkert C, et al. Conference contribution